Regulatory Burden Remains a Material Drag on Healthcare Efficiency, with Physicians Feeling the Greatest Strain

Healthcare leaders consistently cite regulation as both a safeguard and a source of operational drag.

GLP-1 Gold Rush: The $100B Healthcare Market Growing 10% Yearly

This week we’re diving into the 10% annual growing market of GLP-1 and it`s main players.

The GLP-1 Revolution: From Breakthrough Therapy to Healthcare Megatrend

How diabetes drugs became a $100B+ obesity platform—and why their impact is only beginning across healthcare, payers, and the broader economy

22 Deals, $14.5B: Hospital M&A Reaccelerates Fast

Today we’re unpacking the rebound in hospital M&A as systems shift from retrenchment to selective consolidation.

AI Meets Friction, Deals Pick Up, and Pharmacies Go Last-Mile

This week we’re diving into the AI in Healthcare Market, Consumer AI and data integration partnerships details, health industries deal volumes, and mobile pharmacy delivery competitive landscape.

AI in Healthcare

$44B Telehealth Boom + Pharma Repricing Shock

Today we’re unpacking the widening margin gap across healthcare, Big Pharma’s repricing moment, Gilead’s $5B push into ADCs, and Brazil’s evolution into a digital health powerhouse.

Margin Pressure Is No Longer a Sector Story. It Is a Business Model Story.

$890B in Labor. 5.1% Reimbursement. Do the Math.

This week we’re unpacking healthcare’s structural cost squeeze and how AI is becoming the operating system across clinical and administrative workflows.

The Cost Squeeze: Why Healthcare Economics Break in 2025

Healthcare cost inflation is no longer a single-variable problem. It is a system-wide compression cycle where premiums, labor, reimbursement, and consumer affordability are all moving in conflicting directions.

+54% in 3 Years: The Rise of the Self-Pay Patient

Today we’re unpacking the rise of the self-pay patient and the strain on healthcare collections.

The Value-Based Care Shift Just Accelerated: Here’s What You’re Missing

This week we’re diving into the value-based healthcare services market, proprietary David H. Crean expert call, value based care enabler competitive landscape, and biotechnology market trends.